8th January 2010
REGEN THERAPEUTICS PLC
(?ReGen? or the ?Company?; Ticker: (RGT))
TR-1(i): NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the ReGen Therapeutics Plc
underlying issuer of existing shares to
which voting rights are attached (ii):
2. Reason for the notification: An acquisition or disposal of
voting rights
3. Full name of person(s) subject to the Andrew Clement Wilson
notification obligation (iii):
4. Full name of shareholder(s) (if As Above
difference from 3):
5. Date of the transaction and date on 7th January 2010
which the threshold is crossed or reached
(v):
6. Date on which issuer notified: 8th January 2010
7. Threshold(s) that is/are crossed or 5%
reached:
8. Notified details
A: Voting rights attached to shares
Class/type of share if possible using the GB00B28XMY25
ISIN Code
Situation Previous to the triggering
transaction (vi) ?
Number of Shares 2,590,000
Number of Voting Rights (viii) 2,590,000
Resulting situation after the triggering
transaction (viii) ?
Number of Shares 1,527,000
Number of Voting Rights ? Direct (x) 1,527,000
Number of Voting Rights ? Indirect (xi) N/A
% of voting rights ? Direct 4.157%
% of voting rights ? Indirect N/A
B: Financial Instruments
Resulting situation after the triggering
transaction (xii)
Type of financial instrument N/A
Expiration date (xiii) N/A
Exercise/Conversion Period/Date (xiv) N/A
Number of voting rights that may be N/A
acquired if the instrument is
exercised/converted
% of voting rights N/A
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
Resulting situation after the triggering
transaction
Type of financial instrument N/A
Exercise Price N/A
Expiration Date N/A
Exercise Conversion Period N/A
Number of voting rights N/A
Instrument refers to
% of voting rights N/A
Total (A+B+C)
Number of voting rights 1,527,000
% of voting rights 4.157
9. Chain of controlled undertakings
through which the voting rights and/or the
financial instruments are effectively
held, if applicable (xv):
Proxy Voting:
10. Name of the proxy holder: Wapole St Andrews Nominee
11. Number of voting rights proxy holder N/A
will cease to hold:
12. Date on which proxy holder will cease N/A
to hold voting rights:
13. Additional information: N/A
14. Contact name: Patrick Wilson
15. Contact telephone number: 028 90 434040
For further information:
For further information, please contact:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396
David Scott /Nick Bealer
Alexander David Securities Limited
Tel: 020 7448 9800
[HUG#1371846]